Galectin Therapeutics reported $-9935000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Bristol Myers Squibb BMY:US $ 2590M 37M
Gilead Sciences GILD:US $ 2029M 1832M
Idera Pharmaceuticals IDRA:US $ -5.36M 1.18M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Merk MRK:US $ 4927M 642M
Vital Therapies VTL:US $ -20.61M 0.82M
YTE INCY:US $ 254.43M 137.89M